低血磷抗维生素D佝偻病的遗传分型及研究进展

李娜; 王琳; 金春华

doi:10.11852/zgetbjzz2019-1596

PDF(580 KB)

中国儿童保健杂志 ›› 2020, Vol. 28 ›› Issue (12) : 1355-1359. DOI: 10.11852/zgetbjzz2019-1596

综述

低血磷抗维生素D佝偻病的遗传分型及研究进展

李娜, 王琳, 金春华

作者信息 +

Genetic typing and research progress of hypophosphatemic rickets

LI Na, WANG Lin, JIN Chun-hua

Author information +

文章历史 +

摘要

低血磷抗维生素D佝偻病(HR)又称家族性低磷血症或肾性低血磷性佝偻病,是一种以肾磷酸盐丢失、维生素D代谢及骨矿化障碍为特征的单基因遗传性疾病。根据疾病是否受FGF23因子调控,可将疾病大体分为FGF23依赖性HR和非FGF23依赖性HR两大类。目前已经发现多个明确与HR相关的致病基因,包括X-性连锁、常染色体显性、常染色体隐性。本文就低血磷抗维生素D佝偻病的遗传分型及研究进展进行综述。

Abstract

Hypophosphatemic rickets (HR),also known as familial hypophosphatemia or renal hypophosphatemic rickets,is a single gene genetic disease characterized by renal phosphate loss,vitamin D metabolism and bone mineralization disorders.According to whether the disease is regulated by FGF23,the disease can be divided into FGF23 dependent HR and non FGF23 dependent HR.At present,many specific pathogenic genes related to HR have been found,including X-linked,autosomal dominant and autosomal recessive.This paper reviews the genetic typing and research progress of vitamin D rickets.

导出引用

李娜, 王琳, 金春华. 低血磷抗维生素D佝偻病的遗传分型及研究进展[J]. 中国儿童保健杂志. 2020, 28(12): 1355-1359 https://doi.org/10.11852/zgetbjzz2019-1596

LI Na, WANG Lin, JIN Chun-hua. Genetic typing and research progress of hypophosphatemic rickets[J]. Chinese Journal of Child Health Care. 2020, 28(12): 1355-1359 https://doi.org/10.11852/zgetbjzz2019-1596

中图分类号： R591.44

参考文献

[1] Fuente R,Gil-Peña H,Claramunt-Taberner.X-linked hypophosphatemia and growth[J].Rev Endocr Metab Disord,2017,18(1),107-115.
[2] Bitzan M,Goodyer PR.Hypophosphatemic Rickets[J].Pediatr Clin N Am,2019,66(1):179-207.
[3] Chesher D,Oddy M,Darbar U,et al.Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations[J].J Inherit Metab Dis,2018,41(5):865-876.
[4] Ran Q,Xiong F,Zhu M et al.Novel PHEX gene mutations in patients with X-linked hypophosphatemic rickets:an analysis of 2 cases[J].CJCP,2017,19(5):534-538.
[5] Kinoshita Y,Saito T,Shimizu Y,et al.Mutational analysis of patients with FGF23-related hypophosphatemic rickets[J].Eur J Endocrinol,2012,167(2):165-172.
[6] Li SS,Gu JM,Yu WJ,et al.Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets[J].Int J Mol Med,2016,38(6):1703-1714.
[7] 李恬恬,张立琴.X-连锁低血磷性抗维生素D佝偻病基因突变研究进展[J].中国儿童保健杂志,2017,25(12):1233-1235.
[8] Guven A,Al-Rijjal RA,Binessa HA,et al.Mutational analysis of PHEX,FGF23 and CLCN5 in patients with hypophosphataemic rickets[J].Clin Endocr,2017,87(1),103-112.
[9] Seton M,Jüppner H.Autosomal dominant hypophosphatemic rickets in an 85 year old woman:characterization of her disease from infancy through adulthood[J].Bone,2013,52:640-643.
[10] Mualla H,Bae SA,Yaqub A.Autosomal dominant hypophosphatemic rickets presenting in a phenotypically normal adult female[J].Case Rep Endocrinol,2019,2019:8917519.
[11] Liu C,Zhao Z,Wang O,et al.Earlier onset in autosomal dominant hypophosphatemic rickets of R179 than R176 mutations in fibroblast growth factor 23:report of 20 Chinese cases and review of the Literature[J].Calcif Tissue Int,2019,105(5):476-486.
[12] Razali NN,Hwu TT,Thilakavathy K.Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets[J].JPEM,2015,28 (9-10):1009-1017.
[13] Mäkitie O,Pereira RC,Kaitila I,et al.Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation[J].J Bone Miner Res,2010,25:2165-2174.
[14] Ichikawa S,Gerard-O′Riley RL,Acton D,et al.A mutation in the Dmp1 gene alters phosphate responsiveness in mice[J].Endocrinology,2017,158(3):470-476.
[15] Rowe PS.A unified model for bone-renal mineral andenergy metabolism[J].Curr Opin Pharmacol,2015,22:64-71..
[16] Saito T,Shimizu Y,Hori M,et al.A patient withhypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene[J].Bone,2011,49(4):913-916.
[17] Acar S,Demir K,Shi Y.Genetic causes of rickets[J].Clin Res Pediatri Endocrinol,2017,9(Suppl 2):88-105.
[18] Iole B,Tosello Barthélémy,Sophie H,et al.Generalized arterial calcification of infancy with a novel ENPP1 mutation:a case report[J].BMC Pediatrics,2018,18(1):217.
[19] Erben RG.alpha-Klotho′s effects on mineral homeostasis are fibroblast growth factor-23 dependent[J].Curr Opin Nephrol Hypertens,2018,27(4):229-235.
[20] Clemens B,Ken-Ichi M.Hereditary hypophosphatemic rickets with hypercalciuria:pathophysiology,clinical presentation,diagnosis and therapy[J].Pflugers Arch,2019,471(1):149-163.
[21] Yu Y,Sanderson SR,Reyes M,et al.NovelNaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families:long-term follow-up in one kindred[J].Bone,2012;50(5):1100-1106.
[22] Hasani-Ranjbar S,Ejtahed HS,Amoli MM,et al.SLC34A3 intronic deletion in an Iranian Kindred with hereditary hypophosphatemic rickets with hypercalciuria[J].J Clin Res Pediatr Endocrinol,2018,10(4):343-349.
[23] Dhir G,Li D,Hakonarson H,et al.Late-onset hereditary hypophosphatemic rickets with hypercalciuria (HHRH) due to mutation of SLC34A3/NPT2c[J].Bone,2016,97:15.
[24] Demir K,Y1ld1z M,Bahat H,et al.Clinical heterogeneity and phenotypic expansion of NaPi-IIa-associated disease[J].Clin Endocrinol Metab,2017,12(102):4604-4614,
[25] Karim Z,Gerard B,Bakouh N,et al.NHERF1 mutations and responsiveness of renal parathyroid hormone[J].New Eng J Med,2008,359:1128-1135.
[26] Tosetto E,Ceol M,Mezzabotta F,et al.Novel mutations of the CLCN5 gene including a complex allele and a 5-prime UTR mutation in Dent disease 1.(Letter) Clin[J].Genet,2009,76:413-416
[27] Mansour-Hendili L,Blanchard A,Le PN,et al.Mutation update of the CLCN5 gene responsible for dent disease 1[J].Human Mutation,2015,36(8):743-752.
[28] Levin-Iaina N,Dinour D.Renal disease with OCRL1 mutations:dent-2 or lowe syndrome[J].J Pediatr Genet,2012,1:3-5.
[29] Bockenhauer D,Bokenkamp A,Nuutinen M,et al.Novel OCRL mutations in patients with Dent-2 disease[J].J Pediatr Genet,2012,1:15-23.
[30] Devuyst O,Thakker RV.Dent′s disease[J].Orphanet journal of rare diseases,2010,5(1):28.
[31] Hernández-Frías O,Gil-Peña H,Pérez-Roldán JM,et al.Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia[J].Pediatr Nephrol,2019,34:1077.